The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant atezolizumab in resectable NSCLC patients: Updated clinical and immunophenotyping results from a multicenter trial.
 
Filiz Oezkan
Honoraria - Novartis
Consulting or Advisory Role - Epigenomics
Research Funding - Genentech/Roche (Inst)
Travel, Accommodations, Expenses - Genentech/Roche
 
Kai He
Honoraria - Geneplus
Consulting or Advisory Role - Perthera
Research Funding - Adaptimmune (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Mirati Therapeutics (Inst)
 
Dwight Hall Owen
Consulting or Advisory Role - AstraZeneca; L&M Policy Research
 
Maciej Pietrzak
No Relationships to Disclose
 
Valerie W. Rusch
Research Funding - Genelux (Inst); Genentech (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; da Vinci Surgery
 
Jamie E. Chaft
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; Genentech/Roche; Merck
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst)
 
Rhonda Kitzler
No Relationships to Disclose
 
Alan Nicholas
Employment - Genentech
Stock and Other Ownership Interests - Roche
 
Katja Schulze
Employment - Genentech
Stock and Other Ownership Interests - Roche/Genentech
 
Ann Johnson
Employment - Genentech
Stock and Other Ownership Interests - Roche
 
See Phan
Employment - Genentech
Stock and Other Ownership Interests - Roche
 
Paul A. Bunn
Consulting or Advisory Role - Abbvie; AstraZeneca/MedImmune; Bristol-Myers Squibb; Genentech/Roche; Lilly; Merck; Merck Serono; Novartis
Research Funding - Genentech (Inst)
 
Mark G. Kris
Consulting or Advisory Role - AstraZeneca; Pfizer; Regeneron
 
David J. Kwiatkowski
Consulting or Advisory Role - AstraZeneca; Genentech/Roche
Research Funding - AADi
 
Bruce E. Johnson
Research Funding - Novartis (Inst); Novartis (Inst); Toshiba (Inst)
Patents, Royalties, Other Intellectual Property - Dana-Farber Cancer Institute
 
Ignacio Ivan Wistuba
Consulting or Advisory Role - Ariad; AstraZeneca/MedImmune; Asuragen; Bristol-Myers Squibb; Genentech/Roche; HTG Molecular Diagnostics; Lilly; Pfizer
Speakers' Bureau - Boehringer Ingelheim; Bristol-Myers Squibb; MSD Oncology; Pfizer
Research Funding - Adaptimmune; EMD Serono; Genentech; HTG Molecular Diagnostics; MedImmune; Merck; Myriad Genetics; OncoPlex Diagnostics; Pfizer; Silicon Biosytems
 
Jay M. Lee
Consulting or Advisory Role - Genentech/Roche
Research Funding - Genentech/Roche; Merck
Travel, Accommodations, Expenses - Genentech/Roche
 
Fred R. Hirsch
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Clovis Oncology; Genentech; HTG Molecular Diagnostics; Lilly; Merck; Pfizer; Roche; Ventana Medical Systems
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech (Inst); Lilly/ImClone (Inst)
Patents, Royalties, Other Intellectual Property - EGFR FISH and IHC for prediction of outcome in patients treated with EGFR inhibitors (Inst)
 
Gerard Lozanski
Research Funding - Genentech; Innate Pharma; Novartis; Stemline Therapeutics
 
David Paul Carbone
Consulting or Advisory Role - Abbvie; Agenus; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; EMD Serono; Genentech/Roche; Helsinn Healthcare; Incyte; Inivata; Inovio Pharmaceuticals; Janssen; Kyowa Hakko Kirin; Merck; Novartis; Pfizer; prIME Oncology; Takeda
Research Funding - Bristol-Myers Squibb; Gentech